The acquisition of Adenza is expected to significantly boost Nasdaq's software revenue mix. Read why I maintain my strong buy ...

The California-based biotech priced its shares at $18. Its lead product, a weight loss treatment called Azelaprag, is still ...

BioAge Labs is bringing in almost $200 million via its Nasdaq IPO this morning, with the proceeds earmarked for taking its ...

We recently published a list of Top 10 Buzzing AI Stocks Now. Since Astera Labs Inc (NASDAQ:ALAB) ranks 10th on the list, it ...

Cerebras Systems is targeting an IPO to raise up to $1 billion, potentially valuing the company at $7 billion to $8 billion. The company's CS-3 system is tailored to handle complex AI computing ...

BioAge Labs (NASDAQ:BIOA) shares rallied nearly 30% Thursday after the obesity drug developer made its market debut through ...

Shares of XCHG nearly tripled in their first week of trading after the company raised $20.7 million in its Nasdaq IPO The ...

For now, it doesn't seem likely CrowdStrike can generate millionaire-making gains. It's still a decent play on the secular ...

CyberArk has marked the 10th anniversary of its initial public offering by ringing the opening bell at the Nasdaq Stock ...

Shaw's niece Claire Mazumdar's company Bicara Therapeutics made its debut at Nasdaq. For the ringing of the opening bell at ...

RBC assigned Outperform ratings to Nasdaq (NASDAQ:NDAQ) and Intercontinental Exchange (NYSE:ICE) and Sector Perform ratings ...

Biocon founder and Chairperson Kiran Mazumdar-Shaw expressed her pride and joy on Wednesday as her niece, Claire Mazumdar, ...